Effects of olanzapine on ethanol withdrawal syndrome in rats

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 208-214

  Unsalan, Nasibe ^a   Saglam, Esra ^a   Kayir, Hakan ^b   Uzbay, Tayfun ^b  

^a MALTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

(Rat); Ethanol dependence; Ethanol withdrawal syndrome; Olanzapine

Indexed keywords

ALCOHOL; OLANZAPINE; SODIUM CHLORIDE; SUCROSE;

ACUTE DRUG ADMINISTRATION; AGITATION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; BEHAVIOR CHANGE; BODY POSTURE; CALORIC INTAKE; CHRONOTHERAPY; CONTROL GROUP; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; GAIT DISORDER; INCIDENCE; LATENT PERIOD; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; TAIL; TREMOR; WET DOG SHAKES; WISTAR RAT;

ANIMALS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; STEREOTYPED BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 37549016065     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.024     Document Type: Article

References (47)

1. Alldregge B.K. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 53 5 Suppl 2 (1999) S68-S75
2. Brust J.C.M. Neurological Aspects of Substance Abuse. second ed. (2004), Elsevier Butterworth Heinemann, Philadelphia 334
3. Camacho A., García-Navarro M., Martínez B., Villarejo A., and Pomares E. Olanzapine-induced myoclonic status. Clin. Neuropharmacol. 28 (2005) 145-147
4. Ciccocioppo R. The role of serotonin in craving: from basic research to human studies. Alcohol 34 (1999) 244-253
5. Conroy S.K., Rodd Z., and Chambers R.A. Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats. Pharmacol. Biochem. Behav. 86 (2007) 386-394
6. Dall'Olio R., Gandolfi O., Vaccheri A., Roncada P., and Montanaro N. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats. Psychopharmacology 95 (1988) 381-385
7. D'Souza D.C., Gil R.B., Madonick S., Perry E.B., Forselius-Bielen K., Braley G., Donahue L., Tellioglu T., Zimolo Z., Gueorguieva R., and Krystal J.H. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology 31 (2006) 2767-2775
8. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
9. Drake R.E., Xie H., McHugo G.J., and Green A.I. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr. Bull. 26 (2000) 441-449
10. Feldman D.J., Frank R.A., Kehne J.H., Flannery R., Brown D., Soni S., Byrd G., and Shah S. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior. Pharmacol. Biochem. Behav. 58 (1997) 565-572
11. Fone K.C., Robinson A.J., and Marsden C.A. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats. Br. J. Pharmacol. 103 (1991) 1547-1555
12. Frye G.D., McCown T.J., and Breese G.R. Differential sensitivity of ethanol withdrawal signs in the rat to gamma amino butyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors. J. Pharmacol. Exp. Ther. 226 (1983) 720-725
13. Hauber W., and Lutz S. Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav. Brain Res. 106 (1999) 143-150
14. Hauber W., and Münkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmacol. 323 (1997) 127-131
15. Hauber W., Lutz S., and Münkle M. The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats. Neuroscience 86 (1998) 147-157
16. Hedges D., Jeppson K., and Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today 39 (2003) 551-557
17. Heilig M., and Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanism. Pharmacol. Ther. 111 (2006) 855-876
18. Heimer L., Alheid G.F., de Olmos J.S., Groenewegen H.J., Haber S.N., Harlan R.E., and Zahm D.S. The accumbens: beyond the core-shell dichotomy. J. Neuropsychol. Clin. Neurosci. 9 (1997) 354-381
19. Hutchison K.E., Swift R., Rohsenow D.J., Monti P.M., Davidson D., and Almeida A. Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacology 155 (2001) 27-34
20. Hutchison K.E., Wooden A., Swift R.M., Smolen A., McGeary J., Adler L., and Paris L. Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 28 (2003) 1882-1888
21. Jaffe J.H. Drug addiction and drug abuse. In: Gilman A.G., Rall T.W., and Wies A.S. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (1990), Pergamon Press, New York 522-573
22. Kenna G.A., McGeary J.E., and Swift R.M. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 2. Am. J. Health-Syst. Pharm. 61 (2004) 2380-2390
23. Kuriyama K., and Ohkuma S. Alterations in the function of cerebral neurotransmitter receptors during the establishment of alcohol dependence: neurochemical aspects. Alcohol Alcohol. 25 (1990) 239-249
24. Lee J.W., Crismon M.L., and Dorson P.G. Seizure associated with olanzapine. Ann. Pharmacother. 33 (1999) 554-556
25. Le Marquand D., Pihl R.O., and Benkelfat C. Serotonin and alcohol intake, abuse, dependence: clinical evidence. Biol. Psychiatry 36 (1994) 326-337
26. Longoni R., Spina L., and Di Chiara G. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats. Life Sci. 41 (1987) 2135-2145
27. Magnusson O., Fowler C.J., Köhler C., and Ogren S.O. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs. Neuropharmacology 25 (1986) 187-197
28. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 43 (1996) 1993-1996
29. Murphy J.M., McBridge W.J., Lumeng L., and Li T.-K. Contents of monoamines in forebrain regions of alcohol-preferring and nonpreferring lines of rats. Pharmacol. Biochem. Behav. 26 (1987) 389-392
30. Myers R.D., and Martin G.E. The role of cerebral serotonin in the ethanol preference of animals. Ann. N.Y. Acad. Sci. 215 (1973) 135-144
31. Noble E. The gene that rewards alcoholism. Sci. Am. Sci. Med. 3 (1996) 52-61
32. Ortega-Alvaro A., Gibert-Rahola J., and Mico J.A. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 30 (2006) 104-111
33. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993) 247-291
34. Roy A., Virkunnen M., and Linnolia M. Reduced central serotonin turnover in subgroup of alcoholics. Biol. Psychiatry 11 (1987) 173-177
35. Schatzberg A.F., Cole J.O., and DeBattista C. Manuel of Clinical Pharmacology. fourth ed. (2003), American Psychiatric Publishing, Inc., Washington DC 159-244
36. Schuckit M.A. Recent developments in the pharmacotherapy of alcohol dependence. J. Consult. Clin. Psychol. 64 (1996) 669-676
37. Seeman P., Schwarz J., Chen J.F., Szechtman H., Perreault M., McKnight G.S., Roder J.C., Quirion R., Boksa P., Srivastava L.K., Yanai K., Weinshenker D., and Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse 60 (2006) 319-349
38. Takao K., Nagatani T., Kitamura Y., Kawasaki K., Hayakawa H., and Yamawaki S. Chronic forced swim stress of rats increases frontal cortical 5-HT2 receptors and the wet-dog shakes they mediate, but not frontal cortical beta-adrenoceptors. Eur. J. Pharmacol. 294 (1995) 721-726
39. Uzbay I.T., and Kayaalp S.O. A modified liquid diet of chronic ethanol administration: validation by ethanol withdrawal syndrome in rats. Pharmacol. Res. 31 (1995) 37-42
40. Uzbay I.T., Akarsu E.S., and Kayaalp S.O. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol. Biochem. Behav. 49 (1994) 969-974
41. Uzbay I.T., Erden B.F., Tapanyiǧit E.E., and Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. 61 (1997) 2197-2209
42. Uzbay I.T., Usanmaz S.E., Tapanyigit E.E., Aynaci{dotless}oglu S., and Akarsu E.S. Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs. Drug Alcohol Depend. 53 (1998) 39-47
43. Uzbay I.T., Usanmaz S.E., and Akarsu E.S. Effects of chronic ethanol administration on serotonin metabolism in the various regions of the rat brain. Neurochem. Res. 25 (2000) 257-262
44. Uzbay I.T., Yesilyurt O., Celik T., Ergun H., and Isimer A. Effects of agmatine on ethanol withdrawal in rats. Behav. Brain Res. 107 (2000) 153-159
45. Volkow N.D., Fowler J.S., Wang G.J., and Swanson J.M. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Mol. Psychiatry 9 (2004) 557-569
46. Woolley J., and Smith S. Lowered seizure threshold on olanzapine. Br. J. Psychiatry 178 (2001) 85-86
47. Yap C.Y., and Taylor D.A. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat. Neuropharmacology 22 (1983) 801-804